Topic: biomanufacturing


New Drug Pricing Strategies for a Changing Global Market

During this webinar, PwC’s Health Research Institute will review findings from a new global survey of industry executives, and provide analysis and commentary on key drug pricing issues.


Mekonos aims to use silicon nanoneedles to deliver genetic payloads directly into the cell using a purely physical, mechanical form factor, with the goal of greatly lowering the cost and time of developing cell therapies.
Cambridge, MA, and Boston

Moderna to plow $110M into manufacturing build-out

To any other private biotech, sinking $110 million into a custom-built manufacturing facility while its most advanced programs are in Phase II would be unthinkable. But not for Moderna, a prominent Cambridge, MA-based startup that’s deep into so-called unicorn territory with a reported valuation of $5 billion.